EvaMist FDA Approval History
FDA Approved: Yes (First approved July 27, 2007)
Brand name: EvaMist
Generic name: estradiol
Dosage form: Transdermal Spray
Company: VIVUS, Inc.
Treatment for: Postmenopausal Symptoms
EvaMist is an estradiol transdermal spray administered once daily for the treatment of vasomotor symptoms (hot flashes) associated with menopause.
Development Timeline for EvaMist
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.